Literature DB >> 18452684

Sublabial transseptal vs transnasal combined endoscopic microsurgery in patients with Cushing disease and MRI-depicted microadenomas.

John L D Atkinson1, William F Young, Fredric B Meyer, Dudley H Davis, Todd B Nippoldt, Dana Erickson, Adrian Vella, Neena Natt, Charles F Abboud, Paul C Carpenter.   

Abstract

OBJECTIVE: To assess whether the type of surgical approach to the sella (sublabial transseptal vs transnasal) affects surgical outcome among patients with Cushing disease. PARTICIPANTS AND METHODS: Both procedures were performed at our institution from January 1, 1995, through January 31, 2003. From a total of 106 patients with Cushing disease who had had surgery, we identified 42 adults undergoing an initial surgery, with microadenoma (<1 cm) determined by magnetic resonance imaging and a minimal follow-up of 3 months.
RESULTS: We identified 21 patients (4 male, 17 female) for sublabial transseptal transsphenoidal microsurgery. Mean+/-SD age was 45.0+/-12.9 years (range, 27.0-69.0 years); median duration of symptoms was 2.5 years (range, 1.5-7.5 years). Median follow-up was 1.0 year (range, 0.3-11.0 years). We identified another 21 patients (5 male, 16 female) for endoscopic transsphenoidal microsurgery whose mean+/-SD age was 43.8+/-14.1 years (range, 19.0-70.0 years); median duration of symptoms was 2.4 years (range, 0.2-6.0 years). Median follow-up was 2.5 years (range, 0.3-8.7 years). Complications (cerebrospinal fluid leak and transient diabetes insipidus) and cure (86% initial cure; 76% relapse-included cure) were equivalent between the 2 procedures. However, the endoscopic approach was associated with shorter anesthesia time, less blood loss, and shorter hospital stays.
CONCLUSION: The endoscopic transnasal surgical approach led to shorter total anesthesia time, less blood loss, and shorter hospital stay when compared with the sublabial transseptal approach. However, we found no difference between the 2 surgical procedures with respect to cure or complications, suggesting that outcome is more closely related to the experience of the operating team.

Entities:  

Mesh:

Year:  2008        PMID: 18452684     DOI: 10.4065/83.5.550

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  8 in total

1.  Systematic review and network meta-analysis assess the comparative efficacy and safety of transsphenoidal surgery for pituitary tumor.

Authors:  Wei Dai; Zong Zhuang; Haiping Ling; Yongbo Yang; Chunhua Hang
Journal:  Neurosurg Rev       Date:  2020-02-08       Impact factor: 3.042

2.  Single-surgeon fully endoscopic endonasal transsphenoidal surgery: outcomes in three-hundred consecutive cases.

Authors:  Adam N Mamelak; John Carmichael; Vivien H Bonert; Odelia Cooper; Shlomo Melmed
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

3.  Pituitary tumors: our experience in the prevention of postoperative cerebrospinal fluid leaks after transsphenoidal surgery.

Authors:  Alejandra T Rabadán; Diego Hernández; C Santiago Ruggeri
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

4.  Endoscopic vs. microscopic transsphenoidal surgery for Cushing's disease: a systematic review and meta-analysis.

Authors:  Leonie H A Broersen; Nienke R Biermasz; Wouter R van Furth; Friso de Vries; Marco J T Verstegen; Olaf M Dekkers; Alberto M Pereira
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

5.  Microscopic versus endoscopic transsphenoidal surgery in the Leiden cohort treated for Cushing's disease: surgical outcome, mortality, and complications.

Authors:  Leonie H A Broersen; Femke M van Haalen; Nienke R Biermasz; Daniel J Lobatto; Marco J T Verstegen; Wouter R van Furth; Olaf M Dekkers; Alberto M Pereira
Journal:  Orphanet J Rare Dis       Date:  2019-03-11       Impact factor: 4.123

6.  Update in Cushing disease: What the neurosurgeon has to KNOW, on behalf of the EANS skull base section.

Authors:  Sayoa Eulate-Beramendi; Ainhoa Casajús; Lola Ollero; Lynnette K Niemann; Juan Carlos Fernández-Miranda; Michaël Bruneau; Moncef Berhouma; Luigi Maria Cavallo; Jan Frederick Cornelius; Roy T Daniel; Sebastien Froelich; Emmanuel Jouanneau; Ekkehard Kasper; Diego Mazzatenta; Torstein R Meling; Mahmoud Messerer; Henry W S Schroeder; Marcos Tatagiba; Massimiliano Visocchi; Eduard H Voormolen; Idoya Zazpe
Journal:  Brain Spine       Date:  2022-08-07

7.  Endoscopic endonasal trans-sphenoid surgery of pituitary adenoma.

Authors:  Yr Yadav; S Sachdev; V Parihar; H Namdev; Pr Bhatele
Journal:  J Neurosci Rural Pract       Date:  2012-09

8.  Endoscopic versus microscopic transsphenoidal pituitary adenoma surgery: a meta-analysis.

Authors:  Yang Gao; Chunlong Zhong; Yu Wang; Siyi Xu; Yang Guo; Chenyang Dai; Yan Zheng; Yong Wang; Qizhong Luo; Jiyao Jiang
Journal:  World J Surg Oncol       Date:  2014-04-11       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.